Bibliografia Braquiterapia Alta Tasa Cáncer Próstata

1 Zietman AL, De Silvio ML, Slater JD et al. Comparation of convencional dose vs high dose conformal radiotherapy in clinically localizad adenocarcinoma of prostate : a  randomised control trial. JAMA 2005; 294:1233-9

2. Peeters ST., Heemsbergen WD., Koper DC. Et al. Dose-response in radiotherapy for localized prostate cancer. Results on the Dutch multicenter randomised phase III trial comparing 68Gy of radiotherapy with 78 Gy. J Clinical Oncology 2006; 24: 1990-1996.

3. Dearnaley DP., Sydes MR., Graham JD. Et al. Escalated-Dose versus Standard dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomized control trial. Lancet Oncol 2007; 8:475-487.

4. Pollack A., Zagars GK., Starkschall G et al. Prostate cancer radiation dose response : results of the MD Anderson phase III radomized trial. IJROBP 2002; 53: 1097-1105.

5. Hu I-C, Pickett B, Shinohara K et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost : potential for dose escalation .IJROBP 2000; 46: 851-858.

6. Hoskin P. High dose rate brachytherapy for prostate cancer. Cancer radiotherapie. 2008 ; 12 : 512-514.

7. Thomadsen BR., Houdek PV., Edmudson G et al. Treatment planning and optimisation .In Nag S., editor High dose rate (HDR) brachytherapy. A text book .Future publishing company 1994  p 19-145.

8. Fowler J., Camppell R., Ritter M., is alpha/beta for prostate tumors really low?  IJROBP 1999;44:747-748

9. Kovacs G., Potter R., loch T. et al. GEC/ESTRO recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiotherapy and Oncology 2005; 74: 137-148.

10. Borghede  G., Hedelin H., holmang S., et al. Irradiation of localized prostatic carcinoma  with combination of HDR iridium 192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiotherapy and Oncology 1997; 44 : 237- 244.

11. Hoskin P.J., High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiotherapy and Oncology 2000; 57: 285-288.

12. Kovacs G., Wirth B., Bertermann H et al. Prostate preservation by combined external beam and HDR brachytherapy at nodal negative prostate cancer patients- An Intermediate analysis after ten years experience. IJROBP 1996; 36: 198.

13.  Hoskin P.J.,Bowels PJ., Osler P. et al High dose rate brachytherapy for prostate cancer : catether and gland movement between fractions. Radiotherapy and Oncology 2003; 68: 285-288.

14 . Valero J., Cambeiro M., Galan C. Et al . Phase II of radiation dose escalation with conformal external beam radiotherapy and high dose rate brachytherapy combined with long term androgen supresión in infavorable prostate cancer: feasibility study. IJROBP 2010 ; 76(2) :386-392. 

15. Ash D., Flynn A., Batterman J. et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiotherapy and Oncology 2000; 57: 315-321.

16. Mate T., Gottesman J., Fractionated HDR conformal prostate brachytherapy. Presented at the 8 th International Brachytherapy Conference , Nice, France, November 25-28, 1995. Veenendaal The Netherlands : Nucletron International BV; 1995. pp75-78.

17. Mate T., Gottesman J., Hatton J et al High dose afterloading 192 iridium prostate brachytherapy . Feasibility report. IJROBP 1998; 41: 525-533.

18.  Martinez A., Gonzalez J., Stromberg J. Et al. Conformal prostate brachytherapy : initial experience of a phase I/II dose escalating trial. IJROBP 1995; 33: 1019-1027.

19.  Bradley R., Djuna Z., Caro CE., Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer : A systematic review. Radiotherapy and Oncology 2009;93: 168-173.

20. Hoskin PJ., Motohashi K., Bownes P. high dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: inicital results of a randomised phase III trial. Radiotherapy and Oncology 2007;84: 114-120.

21 Martinez A., Gonzalez J., Spencer W., Conformal HDR brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors J Urol 2003; 169 974-979

22. Amstron L., Pedersen D., Mercke C. y cols. Long term results of high dose rate brachytherapy of localised prostate cancer. Radiotherapy and Oncology. 2005; 74: 157-161.

23. Deger S., boehmer D., Turk I et al. High dose rate brachytherapy of localised protate cancer. Eur. Urology 2002; 52: 6-13

24. Demanes DJ., Rodriguez RR., Schour L et al. High dose rate brachytherapy with external beam radiotherapy for prostate cancer. California endocuritherapys¨10 years results . IJROBP 2005; 61: 1306-1316.

25. Martin T., roddiger S., Kurek R et al . 3 D conformal HDR brachytherapy with temporary androgen deprivation in the treatment of localized prostate cancer. Radiotherapy and Oncology 2004; 71:35-41.

26. Kalkner KM., Wahlgren T., Ryberg M. et al. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy HDR iridium 192 brachytherapy boost: a 6 years follow up. Acta Oncologica 2007; 46: 909-917.

27. A Hsu I., Bae K., Shinohara K., Pouliot J et al. Phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.  IJROBP 2010; article in press